New York State Common Retirement Fund Aptinyx Inc. Transaction History

New York State Common Retirement Fund

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 02, 2021	SELL	$2.21 - $2.89 $609 - $797	-276 Closed	0 $0
Q2 2021 Aug 02, 2021	SELL	$2.39 - $3.5 $36,385 - $53,284	-15,224 Reduced 98.22%	276 $1,000
Q4 2020 Feb 08, 2021	BUY	$2.93 - $4.3 $44,536 - $65,360	15,200 Added 5066.67%	15,500 $54,000
Q3 2020 Nov 05, 2020	SELL	$3.05 - $4.99 $71,065 - $116,267	-23,300 Reduced 98.73%	300 $1,000
Q2 2020 Aug 07, 2020	BUY	$1.99 - $4.4 $46,964 - $103,840	23,600 New	23,600 $98,000
Q2 2019 Aug 09, 2019	SELL	$2.95 - $4.38 $35,591 - $52,844	-12,065 Closed	0 $0
Q4 2018 Feb 08, 2019	BUY	$16.15 - $28.93 $194,849 - $349,040	12,065 New	12,065 $200,000

Ticker APTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,715,696
Description
Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.